A carregar...

Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01)

INTRODUCTION: Pathologic complete response (pCR) after neoadjuvant chemotherapy has a demonstrated survival advantage; however, outcomes for non-pCR by receptor status are less understood. We sought to evaluate survival and distant recurrence by receptor status for patients with residual stage II/II...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Stankowski-Drengler, TJ, Schumacher, JR, Hanlon, B, Livingston-Rosanoff, D, Vande Walle, K, Greenberg, CC, Wilke, LG, Neuman, HB
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7590230/
https://ncbi.nlm.nih.gov/pubmed/31900808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-019-07846-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!